Vanishing high-risk thyroid nodule following pembrolizumab-induced destructive thyroiditis: case report and focused literature review
{{output}}
Background: Destructive thyroiditis is among the most frequent endocrine adverse events of immune checkpoint inhibitors (ICIs). Most reports focus on thyroid dysfunction; less is known about how ICI-induced destructive thyroiditi... ...
